Implications of the diabetes prevention program and look AHEAD clinical trials for lifestyle interventions

被引:57
作者
Delahanty, Linda M. [1 ]
Nathan, David M. [1 ]
机构
[1] Massachusetts Gen Hosp, MGH Diabet Ctr, Boston, MA 02114 USA
关键词
D O I
10.1016/j.jada.2008.01.026
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The Diabetes Prevention Program DPP) and Look AHEAD (Action for Health in Diabetes) trials are long-term randomized clinical trials that have the potential to direct diabetes care and medical nutrition therapy for obesity, prediabetes, and type 2 diabetes both now and in the future. This article summarizes and compares the important evidence-based results of these diabetes and obesity clinical trials and reviews the similarities and differences in lifestyle interventions that were designed for these trials. Although there were many similarities in the features of the DPP and Look AHEAD interventions, the Look AHEAD lifestyle intervention was more ambitious in several ways: higher individual weight-loss goals, lower calorie and fat-gram targets based on initial body weight, more intensive intervention frequency, combining closed group and individual session format, and use of more structured nutrition intervention strategies from the outset, including meal replacements, structured menus, and combined fat and calorie counting. Evidence, knowledge, and insights gained from working on these clinical trials will be very important in determining the strategies, methods, and approaches needed to make sure that the results of these trials will be fully applied in real-world practice settings for obesity, prediabetes, and type 2 diabetes.
引用
收藏
页码:S66 / S72
页数:7
相关论文
共 27 条
  • [1] Ackermann RT, 2007, DIABETES, V56, pA43
  • [2] Aldana SG, 2005, AAOHN J, V53, P506
  • [3] Aldana Steven, 2006, AAOHN J, V54, P389
  • [4] Aldana Steven G, 2005, AAOHN J, V53, P499
  • [5] Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes
    Brancati, F
    Charleston, J
    Cheskin, L
    Clark, J
    DiGregorio-Celnik, D
    Friedman-Donze, L
    Rubin, R
    Stewart, K
    Bray, GA
    DeLee, DG
    Boss, KR
    Greenway, FL
    Lovejoy, JC
    Ryan, DH
    Williamson, DA
    West, DS
    DiLillo, V
    Raczynski, JM
    Lewis, CE
    Oberman, A
    Thomas, S
    Nathan, DM
    Horton, ES
    Turgeon, H
    Jackson, SD
    Blackburn, GL
    Delahanty, L
    Steiner, B
    Cagliero, E
    Mantzoros, C
    Hill, JO
    Phillipp, J
    Hamman, RF
    Schwartz, R
    Regensteiner, J
    Van Dorsten, B
    McDermott, MT
    Dills, DG
    Foreyt, JP
    Reeves, RS
    Pownell, HJ
    Balasubramanyam, A
    Jones, PH
    Saad, MF
    Jinagouda, S
    Chiu, K
    Morales, L
    Ghazarian, S
    Navarrete, G
    Iqbal, N
    [J]. CONTROLLED CLINICAL TRIALS, 2003, 24 (05): : 610 - 628
  • [6] Bray GA, 1999, DIABETES CARE, V22, P623
  • [7] *CDCP NAT CTR CHR, 1996, PHYS ACT HLTH REP SU
  • [8] Research navigating the course of clinical practice in diabetes
    Delahanty, LM
    Nathan, DM
    [J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2004, 104 (12) : 1846 - 1853
  • [9] Diabet Prevention Program Res Grp, 2005, DIABETES, V54, P1566
  • [10] Ditschuneit HH, 1999, AM J CLIN NUTR, V69, P198